Viral Infections in Special Populations

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".

Deadline for manuscript submissions: 31 August 2024 | Viewed by 901

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, University General Hospital of Patras, 26504 Rio, Greece
Interests: sepsis; COVID-19; HIV; infections in obstetrics and gynecology; antimicrobial resistance; hospital-acquired infections
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue, "Viral Infections in Special Populations", delves into the nuanced landscape of viral afflictions within distinctive patient groups, spanning a myriad of demographics and medical conditions. This comprehensive compilation aims to unravel the intricate intersections between viral infections and vulnerable populations, including but not limited to individuals grappling with HIV, pregnancy or lactation, compromised immunity, advanced age, hematologic disorders, renal replacement therapy, liver cirrhosis, obesity, critical disease requiring ICU, pediatrics, adolescence, etc. Through a multidisciplinary lens, this Special Issue aspires to elucidate the unique challenges, pathophysiological mechanisms, diagnostic intricacies, therapeutic approaches, and preventive strategies pertinent to each specialized cohort. By amalgamating diverse research paradigms, clinical insights, and evidence-based practices, the primary goal is to furnish clinicians, researchers, and healthcare providers with a holistic understanding of viral infections within these distinct populations. Ultimately, this specialized compendium endeavors to catalyze advances in tailored interventions, optimize patient care, and foster pivotal breakthroughs in mitigating the impact of viral illnesses across diverse and vulnerable patient subsets.

Dr. Karolina Akinosoglou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • viral infections
  • HIV
  • pregnancy and lactation
  • immunocompromised population
  • elderly
  • hematological patients
  • patients on renal replacement therapy
  • liver cirrhosis
  • obesity
  • pediatric population and adolescents
  • critically ill patients
  • moving populations

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Other

7 pages, 197 KiB  
Brief Report
Hereditary Connective Tissue Diseases and Risk of Post-Acute SARS-CoV-2
by Maggie L. Bartlett, Daniel Sova and Mahim Jain
Viruses 2024, 16(3), 461; https://doi.org/10.3390/v16030461 - 17 Mar 2024
Viewed by 727
Abstract
We completed a retrospective review of data collected by the JH-CROWN consortium based on ICD10 codes for a hospitalized cohort. The severity and prevalence of COVID-19 and development of PASC within heritable connective tissue diseases were unknown; however, clinical observation suggested a thorough [...] Read more.
We completed a retrospective review of data collected by the JH-CROWN consortium based on ICD10 codes for a hospitalized cohort. The severity and prevalence of COVID-19 and development of PASC within heritable connective tissue diseases were unknown; however, clinical observation suggested a thorough examination was necessary. We compared rates of disease severity, death, and PASC in connective tissue diseases versus the entire cohort as well as in diabetes and hypertension to determine if connective tissue disease was a risk factor. Of the 15,676 patients in the database, 63 (0.40%) had a connective tissue disease, which is elevated relative to the distribution in the population, suggesting a higher risk of severe disease. Within these 63 patients, 9.52% developed PASC compared to 2.54% in the entire cohort (p < 0.005). Elucidation of populations at high risk for severe disease and development of PASC is integral to improving treatment approaches. Further, no other study to date has examined the risk in those with connective tissue diseases and these data support a need for enhanced awareness among physicians, patients, and the community. Full article
(This article belongs to the Special Issue Viral Infections in Special Populations)
Back to TopTop